Choose choice – choose Patheon.
Patheon has transformed an exceptional number of complex new chemical entities into immediate-release tablet products, helping customers to accomplish stabilization and take advantage of the most popular and low-cost dose form. We streamline the path from early development all the way through commercial production. For example, we can help you achieve proof of concept with a powder-filled capsule, then make a rapid transfer to immediate-release tablet with the minimal formulation changes to keep your project moving forward quickly.
Through Patheon you'll have access to the widest range of formulation methods and technologies in many immediate-release tablet dose formats, each in a variety of shapes and sizes:
- Coated and Uncoated Tablets
- Bilayer Tablets
- Trilayer Tablets
- Fast Dispersible Tablets
- Bilayer Chewable Tablets
- Sublingual Tablets
What's more, customers with highly potent compounds enjoy the same expertise and breadth of choices.
At Patheon, science drives the development of your optimal formulation. We are not tied to any proprietary technologies, so you'll never pay us a royalty. Our customers come back to us again and again simply because we do a great job. In fact, our approach has earned Patheon trust across the industry: 19 of the top 20 pharmaceutical companies are clients, as are 8 of the top 10 specialty pharmaceutical companies and 9 of the top 10 biotech companies.
Choice, experience and commitment – They are what has made Patheon #1 globally in pharmaceutical development services.